ROIV
Roivant Sciences Ltd
39.80$
-0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 26.1% | 1.7% | 8.6% | 16.2% | 9.6% | 4.9% | 3.1% | 15.6% | |
| 73.9% | 98.3% | 91.4% | 83.8% | 90.4% | 95.1% | 96.9% | 84.4% | |
| 22,073.8% | 388.9% | 994.4% | 873.7% | 1,440.1% | 1,344.8% | 1,894.5% | 8,254.4% | |
| 10,207.1% | 496.0% | 1,092.2% | 1,401.9% | 1,216.1% | 1,272.1% | 2,035.6% | 7,390.6% | |
| 32,280.9% | 884.9% | 4,591.9% | 2,275.6% | 2,656.2% | 2,616.8% | 3,930.1% | 15,645.0% | |
| -32,207.0% | -786.6% | -4,500.5% | -2,191.8% | -2,565.9% | -2,521.7% | -3,833.3% | -15,560.6% | |
| 324.3% | 11.4% | 11.8% | 12.7% | 88.7% | 106.3% | – | – | |
| -34,732.4% | -828.8% | -3,776.2% | -1,670.9% | -2,806.8% | 13,963.4% | -2,346.0% | -3,203.1% | |
| 112.9% | 10.5% | 7.1% | 0.7% | 12.9% | 65.7% | 165.8% | 1,614.2% | |
| -44,835.2% | 1,773.6% | -3,400.9% | -1,528.9% | -3,200.2% | 13,294.2% | -592.0% | -3,629.2% | |
| 5,943.5% | -817.4% | -3,764.4% | -1,647.4% | -2,658.3% | 14,137.1% | -2,297.6% | -3,162.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.